Information:
Error:
ID
31672
Description
Synthetic Genistein (BONISTEIN™) in Patients Who Are Undergoing Surgery for Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00546039
Link
https://clinicaltrials.gov/show/NCT00546039
Keywords
Versions (1)
- 9/19/18 9/19/18 -
Copyright Holder
See clinicaltrials.gov
Uploaded on
September 19, 2018
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Prostatic Neoplasms NCT00546039
Eligibility Prostatic Neoplasms NCT00546039
- StudyEvent: Eligibility
Similar models
Eligibility Prostatic Neoplasms NCT00546039
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Prostate carcinoma TNM clinical staging
Item
histological proven prostate cancer clinical stage t1c or t2.
boolean
C0600139 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
C3258246 (UMLS CUI [1,2])
Radical prostatectomy Required
Item
are to be treated by radical prostatectomy 3 to 6 weeks after consent.
boolean
C0194810 (UMLS CUI [1,1])
C1514873 (UMLS CUI [1,2])
C1514873 (UMLS CUI [1,2])
Informed Consent
Item
have signed the informed consent form.
boolean
C0021430 (UMLS CUI [1])
Hormone Therapy | Chemotherapy
Item
have been on previous or concurrent hormonal therapy or chemotherapy.
boolean
C0279025 (UMLS CUI [1])
C0392920 (UMLS CUI [2])
C0392920 (UMLS CUI [2])
Neoplasms, Hormone-Dependent
Item
history of previous or other hormone dependent malignancies.
boolean
C0027661 (UMLS CUI [1])
Thyroid Disease | Thyroid hormone replacement therapy
Item
concomitant thyroid disease or are currently taking thyroid hormone replacement medication.
boolean
C0040128 (UMLS CUI [1])
C2242640 (UMLS CUI [2])
C2242640 (UMLS CUI [2])
Soy High dose | Micronutrients High dose | Herbal Supplements High dose
Item
on current high dose soy, micronutrient or herbal supplements.
boolean
C0037733 (UMLS CUI [1,1])
C0444956 (UMLS CUI [1,2])
C0282575 (UMLS CUI [2,1])
C0444956 (UMLS CUI [2,2])
C1504473 (UMLS CUI [3,1])
C0444956 (UMLS CUI [3,2])
C0444956 (UMLS CUI [1,2])
C0282575 (UMLS CUI [2,1])
C0444956 (UMLS CUI [2,2])
C1504473 (UMLS CUI [3,1])
C0444956 (UMLS CUI [3,2])
Soy | Vegetarian food | Dietary Habits Extreme
Item
on soy or vegetarian nutrition or have any other extreme dietary habits.
boolean
C0037733 (UMLS CUI [1])
C0453866 (UMLS CUI [2])
C0086152 (UMLS CUI [3,1])
C0205403 (UMLS CUI [3,2])
C0453866 (UMLS CUI [2])
C0086152 (UMLS CUI [3,1])
C0205403 (UMLS CUI [3,2])
Oral anticoagulants
Item
on oral anticoagulants.
boolean
C0354604 (UMLS CUI [1])
Liver diseases | Pancreatic Diseases
Item
history of liver or pancreas diseases.
boolean
C0023895 (UMLS CUI [1])
C0030286 (UMLS CUI [2])
C0030286 (UMLS CUI [2])
Hypersensitivity Genistein | Hypersensitivity Soy product
Item
history of hypersensitivity to genistein or soy containing products.
boolean
C0020517 (UMLS CUI [1,1])
C0061202 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C1532456 (UMLS CUI [2,2])
C0061202 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C1532456 (UMLS CUI [2,2])
Malabsorption Interferes with Absorption Investigational New Drugs
Item
have a malabsorption condition which might interfere with absorption of the investigational product.
boolean
C3714745 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C0237442 (UMLS CUI [1,3])
C0013230 (UMLS CUI [1,4])
C0521102 (UMLS CUI [1,2])
C0237442 (UMLS CUI [1,3])
C0013230 (UMLS CUI [1,4])